Anti-IL-6/IFNb2 Antibody (Clazakizumab)
Catalog No.
F1271
Anti-IL-6/IFNb2 Antibody (Clazakizumab)
Featured Products
Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may help inhibit cytokine responses to SARS-CoV-2 in COVID-19. Clazakizumab may be used in studies of psoriatic arthritis (PsA) and renal antibody-mediated rejection.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.24 kDa
Dry ice
1236278-28-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ALD518, BMS-945429, BMS945429
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05231
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-6 / IFNb2
Please avoid freeze-thaw cycles.